PRCT
22.09 USD
+5.56%
Today
+9.05%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
PROCEPT BioRobotics Corporation
Currency
USD
Market Cap
1.16B
Avg Daily Volume
1.32M
52 Week High
38.11 USD
52 Week Low
16.665 USD
Trading Hours
See hours
Business Summary
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Top News
PROCEPT.BioRobotics
+16.02%
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
tradingview.com
3w ago
PROCEPT.BioRobotics
+16.02%
PROCEPT BioRobotics Corporation (PRCT) Sets Q3 2026 Results Date
tradingview.com
3w ago
PROCEPT.BioRobotics
+16.02%
PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change
finance.yahoo.com
3w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
